Bronchial Lung Volume Reduction
Jupiter Medical Center’s Thoracic Surgery and Lung Center is offering
a new lung valve treatment for patients with severe COPD/emphysema. Recently
approved by the FDA under their “Breakthrough Devices” status,
the Zephyr Endobronchial Valve treatment representants a major advancement
because it is the first minimally invasive procedure to help emphysema
sufferers breathe easier without major surgery. Done through a simple
bronchoscopy, the valves improve patients’ quality of life by allowing
them to breathe easier, be less short of breath, and be more active and
The one-time procedure is done during a simple bronchoscopy that requires
no cutting or incisions. During the procedure, on average 4 tiny valves
are placed in the airways to block off the diseased parts of the lungs
where air gets trapped. Keeping air from getting trapped in the diseased
parts of the lung allows the healthier parts of the lungs to expand and
take in more air. This results in patients being able to breathe easier
and have less shortness of breath.
Emphysema is a progressive and life-threatening lung disease, and a severe
form of COPD (chronic pulmonary obstructive disease). There is no cure
and patients live with severe shortness of breath that keeps them from
doing simple daily activities like walking, or taking a shower, without
pausing to catch their breath or resting. This extreme shortness of breath
is caused when air becomes trapped in parts of the lung that are damaged
by the disease. This trapped air causes the damaged areas of the lungs
to get larger which puts pressure on the healthy parts of the lungs and
diaphragm. During this short procedure, on average a physician places
4 tiny valves in the airways to block off the damage areas of the lungs
so air no longer gets trapped there. This allows the healthier parts of
the lungs to expand and relieves the pressure on the diaphragm, which
decreases shortness of breath and makes breathing easier.
More on the Zephyr Valves:
The Zephyr® Valves were fast-tracked through the FDA’s “Breakthrough
Device” status because they “offer bronchoscopic lung volume
reduction without surgery and its associated risks.” The FDA’s
approval was based on the results of four randomized controlled clinical
trials, including the US approval study, LIBERATE. Data from the study
showed that implantation of the Zephyr Valves successfully reduced shortness
of breath while improving lung function, exercise capacity, and quality of life.1 These benefits lasted at least one-year post-treatment for patients with
The Zephyr Valves were approved by the FDA in July 2018. Since 2007, more
than 15,000 patients have been treated with The Zephyr Valve worldwide.
Zephyr Valve treatment is included in emphysema treatment recommendations
issued by leading health organizations worldwide, including the Global
Initiative for Chronic Obstructive Lung Disease (GOLD) and the UK’s
National Institute for Health and Care Excellence (NICE).
COPD / Emphysema Treatment
Zephyr® Endobronchial Valve Procedure
What is the Zephyr® Valve:
The first FDA-approved, minimally-invasive device available in the U.S.
for treating patients with severe emphysema.
Who is the Zephyr® Valve for?
Severe emphysema patients who consistently feel short of breath despite
using COPD medications and/or oxygen.
What are the Benefits of Zephyr® Valves?
Patients report being able to take full breaths immediately after the procedure
and within a few days are back to doing everyday tasks with ease. In clinical
studies patients treated with Zephyr® Valves have been shown to1:
- Breathe easier
- Be more active and energetic
- Be less short of breath
- Enjoy a significantly improved quality of life compared to untreated patients.
How does the Procedure Work?
The one-time procedure is done during a bronchoscopy that requires no cutting
or incisions. During the procedure, on average 4 tiny valves are placed
in the airways to block off the diseased parts of the lungs. The valves
reduce hyperinflation, preventing air from being trapped in the diseased
area of the lung and allowing healthier parts of the lung to take in more
air. This results in patients being able to breathe easier. Patients treated
have reported immediate relief.
What can Patients Expect?
A typical Zephyr® valve procedure looks like this:
- The doctor will give you medicine to make you sleepy.
- A small tube with a camera, called a bronchoscope, will be inserted into
your lungs through your nose or mouth.
- During the procedure on average the doctor will place 4 Zephyr Valves in
- You will stay in the hospital for approximately 3 nights for observation.
- After the procedure, you will continue to use the medicines that your doctor
has prescribed for your condition.
To find a Jupiter Medical Center physician who performs Bronchial Lung
Volume Reduction, call 561-263-5737.